Dr. Ioachimescu is a board certified endocrinologist with expertise in the diagnosis and treatment of pituitary tumors.
Titles and Roles
- Emory Pituitary Center
- Associate Professor, Departments of Medicine and Neurosurgery
- Emory University School of Medicine
- Brain and Spine Tumors
- Research Program
- Discovery and Developmental Therapeutics
Adriana Ioachimescu, MD, PhD, began practicing with Emory Healthcare in 2008 and is board certified in both endocrinology and internal medicine. Her areas of expertise include pituitary hormone deficiencies, Cushing syndrome, acromegaly, hyperprolactinemia, and adrenal nodules. She holds memberships in the Endocrine Society, the Pituitary Society, the American Association of Clinical Endocrinologists, American Federation for Medical Research (AFMR) and the Southern Society for Clinical Investigation.
Dr. Ioachimescu attended medical school at Carol Davila University of Medicine in Bucharest, Romania, where she also earned her PhD in neuroendocrinology. She completed her internship at the Yale University Danbury Hospital. She completed her residency and fellowship at the Cleveland Clinic where she was faculty before joining Emory.
Dr. Ioachimescu has received numerous awards including Mentor of the Year from the endocrine fellows of the Division of Endocrinology and Metabolism, the Mara Lieberman Award from the Endocrine Society, the Endocrine Fellows Grant Award from the Endocrine Fellows Foundation, and the Yong Investigator Award from the American Association of Clinical Endocrinologists (AACE). Dr. Ioachimescu is an elected a fellow of the American College of Endocrinology and member of board of directors of Georgia Chapter of AACE. Dr. Ioachimescu is a past president of the Southern Chapter of the AFMR.
Dr. Ioachimescu's research focuses on pituitary tumors' pathogenesis and outcomes, with the purpose of validation of prognostic markers and identification of novel therapies. She is a principal investigator for several multicentric trials that offer cutting edge medical treatment for patients with acromegaly and Cushing's syndrome.